<p>China Resources Pharmaceutical (03320.HK) announced that its subsidiary KPC (600422.SH) achieved an operating revenue of 4.751 billion RMB in the first three quarters, a year-on-year decrease of 18.1%. It recorded a net profit of 323 million RMB, a decline of 35.8%</p>

600422

<p>China Resources Pharmaceutical announced that its subsidiary KPC reported operating revenue of 4.751 billion RMB for the first three quarters, a year-on-year decrease of 18.1%. It recorded a net profit of 323 million RMB, a decline of 35.8%</p>

China Resources Pharmaceutical's subsidiary KPC earned 323 million yuan in the first three quarters, a decline of 35.8%